Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer

Renowned microbiologist will bring clinical expertise as the company advances its platform for rapid pathogen identification and antibiotic susceptibility testing AUSTIN, Texas — March 10, 2022 — Pattern Bioscience, Inc., developer of Digital Culture™ technology for rapid, direct-from-specimen pathogen identification and phenotypic antimicrobial susceptibility testing (ID/AST), announced the appointment of Carey-Ann Burnham, PhD, as chief […] The post Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer appeared first on Pattern Bioscience .